| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Barsness GW, Chaudhry SP, Chonde MD, Cooper HA, Ginder C, Jentzer JC, Kontos MC, Miller PE, Newby LK, O'Brien CG, Park JG, et al. Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. Circulation. Heart Failure. PMID 38587438 DOI: 10.1161/CIRCHEARTFAILURE.124.011736 |
0.01 |
|
| 2024 |
Papolos AI, Kenigsberg BB, Singam NSV, Berg DD, Guo J, Bohula EA, Katz JN, van Diepen S, Morrow DA. Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock. Journal of Cardiac Failure. PMID 38513886 DOI: 10.1016/j.cardfail.2024.02.021 |
0.01 |
|
| 2024 |
Berg DD, Singal S, Palazzolo M, Baird-Zars VM, Bofarrag F, Bohula EA, Chaudhry SP, Dodson MW, Hillerson D, Lawler PR, Liu S, O'Brien CG, Pisani BA, Racharla L, Rowsell RO, et al. Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network. Journal of Cardiac Failure. PMID 38387758 DOI: 10.1016/j.cardfail.2024.01.012 |
0.01 |
|
| 2024 |
Koerber DM, Katz JN, Bohula E, Park JG, Dodson MW, Gerber DA, Hillerson D, Liu S, Pierce MJ, Prasad R, Rose SW, Sanchez PA, Shaw J, Wang J, Jentzer JC, et al. Variation in risk-adjusted Cardiac Intensive Care Unit (CICU) length of stay and the association with in-hospital mortality: an analysis from the Critical Care Cardiology Trials Network (CCCTN) registry. American Heart Journal. PMID 38369218 DOI: 10.1016/j.ahj.2024.02.010 |
0.01 |
|
| 2024 |
Patel SM, Braunwald E, Steffel J, Boriani G, Palazzolo MG, Antman EM, Bohula EA, Carnicelli AP, Connolly SJ, Eikelboom J, Gencer B, Granger CB, Morrow DA, Patel MR, Wallentin L, et al. Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibrillation. Circulation. PMID 38264923 DOI: 10.1161/CIRCULATIONAHA.123.066279 |
0.01 |
|
| 2024 |
Donnelly S, Barnett CF, Bohula EA, Chaudhry SP, Chonde MD, Cooper HA, Daniels LB, Dodson MW, Gerber D, Goldfarb MJ, Guo J, Kontos MC, Liu S, Luk AC, Menon V, et al. Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry. Circulation. Cardiovascular Quality and Outcomes. e010092. PMID 38179787 DOI: 10.1161/CIRCOUTCOMES.123.010092 |
0.01 |
|
| 2023 |
Metkus TS, Alviar CL, Baird-Zars VM, Barsness GW, Berg DD, Bohula EA, Burke JA, Fordyce CB, Guo J, Katz JN, Keeley EC, Menon V, Miller PE, O'Brien CG, Sinha SS, et al. Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery. Jacc. Advances. 2. PMID 38357248 DOI: 10.1016/j.jacadv.2023.100260 |
0.01 |
|
| 2023 |
Bohula EA, Marston NA, Ruzza A, Murphy SA, De Ferrari GM, Diaz R, Leiter LA, Elliott-Davey M, Wang H, Bhatia AK, Giugliano RP, Sabatine MS. Rationale and Design of the Effect of EVolocumab in PatiEntS at High CArdiovascuLar RIsk WithoUt Prior Myocardial Infarction or Stroke (VESALIUS-CV) Trial. American Heart Journal. PMID 38160917 DOI: 10.1016/j.ahj.2023.12.004 |
0.01 |
|
| 2023 |
Patel SM, Morrow DA, Bellavia A, Berg DD, Bhatt DL, Jarolim P, Leiter LA, McGuire DK, Raz I, Steg PG, Wilding JPH, Sabatine MS, Wiviott SD, Braunwald E, Scirica BM, ... Bohula EA, et al. Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61. European Journal of Heart Failure. PMID 38131261 DOI: 10.1002/ejhf.3118 |
0.01 |
|
| 2023 |
Miller PE, Huber K, Bohula EA, Krychtiuk KA, Pöss J, Roswell RO, Tavazzi G, Solomon MA, Kristensen SD, Morrow DA. Research Priorities in Critical Care Cardiology: JACC Expert Panel. Journal of the American College of Cardiology. 82: 2329-2337. PMID 38057075 DOI: 10.1016/j.jacc.2023.09.828 |
0.01 |
|
| 2023 |
Bhatt AS, Berg DD, Palazzolo MG, Alviar CL, Bohula EA, Morrow DA. Resource Use Among Patients with Transcatheter Cardiac Valve Procedures Admitted to Contemporary Cardiac Intensive Care Units: Insights from CCCTN. European Heart Journal. Acute Cardiovascular Care. PMID 37798090 DOI: 10.1093/ehjacc/zuad118 |
0.01 |
|
| 2023 |
Berg DD, Kaur G, Bohula EA, Baird-Zars VM, Alviar CL, Barnett CF, Barsness GW, Burke JA, Chaudhry SP, Chonde M, Cooper HA, Daniels LB, Dodson MW, Gerber DA, Ghafghazi S, et al. Prognostic Significance of Hemodynamic Parameters in Patients with Cardiogenic Shock. European Heart Journal. Acute Cardiovascular Care. PMID 37640029 DOI: 10.1093/ehjacc/zuad095 |
0.01 |
|
| 2023 |
Weber BN, Garshick M, Abbate A, Youngstein T, Stewart G, Bohula E, Plein S, Mukherjee M. Acute Cardiovascular Complications of Immune-Mediated Systemic Inflammatory Diseases. European Heart Journal. Acute Cardiovascular Care. PMID 37603839 DOI: 10.1093/ehjacc/zuad096 |
0.01 |
|
| 2023 |
Berg DD, Moura FA, Bellavia A, Scirica BM, Wiviott SD, Bhatt DL, Raz I, Bohula EA, Giugliano RP, Park JG, Feinberg MW, Braunwald E, Morrow DA, Sabatine MS. Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus. Journal of the American College of Cardiology. 81: 2391-2402. PMID 37344040 DOI: 10.1016/j.jacc.2023.04.031 |
0.01 |
|
| 2023 |
Kadosh BS, Berg DD, Bohula EA, Park JG, Baird-Zars VM, Alviar C, Alzate J, Barnett CF, Barsness GW, Burke J, Chaudhry SP, Daniels LB, DeFilippis A, Delicce A, Fordyce CB, et al. Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit. Jacc. Heart Failure. PMID 37318422 DOI: 10.1016/j.jchf.2023.04.007 |
0.01 |
|
| 2023 |
Tamura T, Cheng C, Chen W, Merriam LT, Athar H, Kim YH, Manandhar R, Amir Sheikh MD, Pinilla-Vera M, Varon J, Hou PC, Lawler PR, Oldham WM, Seethala RR, Tesfaigzi Y, ... ... Bohula EA, et al. Single-cell transcriptomics reveal a hyperacute cytokine and immune checkpoint axis after cardiac arrest in patients with poor neurological outcome. Med (New York, N.Y.). PMID 37257452 DOI: 10.1016/j.medj.2023.05.003 |
0.01 |
|
| 2023 |
Freedman BL, Berg DD, Scirica BM, Bohula EA, Goodrich EL, Sabatine MS, Morrow DA, Bonaca MP. Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial. Clinical Cardiology. PMID 36691960 DOI: 10.1002/clc.23972 |
0.01 |
|
| 2023 |
Bhatt AS, Daniels LB, de Lemos J, Goodrich E, Bohula EA, Morrow DA. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. American Heart Journal. 258: 149-156. PMID 36669711 DOI: 10.1016/j.ahj.2022.12.014 |
0.01 |
|
| 2022 |
Carnicelli AP, Keane R, Brown KM, Loriaux DB, Kendsersky P, Alviar CL, Arps K, Berg DD, Bohula EA, Burke JA, Dixson JA, Gerber DA, Goldfarb M, Granger CB, Guo J, et al. Characteristics, Therapies, and Outcomes of In-Hospital vs Out-of-Hospital Cardiac Arrest in Patients Presenting to Cardiac Intensive Care Units: From the Critical Care Cardiology Trials Network (CCCTN). Resuscitation. PMID 36521683 DOI: 10.1016/j.resuscitation.2022.12.002 |
0.01 |
|
| 2022 |
Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Barnett CF, Barsness GW, Chaudhry SP, Daniels LB, van Diepen S, Ghafghazi S, Goldfarb MJ, Jentzer JC, Katz JN, Kenigsberg BB, Lawler PR, et al. Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry. Circulation. Heart Failure. e009714. PMID 36458542 DOI: 10.1161/CIRCHEARTFAILURE.122.009714 |
0.01 |
|
| 2022 |
Kato ET, Morrow DA, Guo J, Berg DD, Blazing MA, Bohula EA, Bonaca MP, Cannon CP, de Lemos JA, Giugliano RP, Jarolim P, Kempf T, Kristin Newby L, O'Donoghue ML, Pfeffer MA, et al. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. European Heart Journal. PMID 36303404 DOI: 10.1093/eurheartj/ehac577 |
0.01 |
|
| 2022 |
Thomas A, van Diepen S, Beekman R, Sinha SS, Brusca SB, Alviar CL, Jentzer J, Bohula EA, Katz JN, Shahu A, Barnett C, Morrow DA, Gilmore EJ, Solomon MA, Miller PE. Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients: From Pathophysiology to Clinical Practice. Jacc Advances. 1. PMID 36238193 DOI: 10.1016/j.jacadv.2022.100065 |
0.01 |
|
| 2022 |
Siddiqi HK, DeFilippis EM, Biery DW, Singh A, Wu WY, Divakaran S, Berman A, Rizk T, Januzzi JL, Bohula E, Stewart G, Carli MD, Bhatt DL, Blankstein R. Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock after Acute Myocardial Infarction. Journal of Cardiac Failure. PMID 36130688 DOI: 10.1016/j.cardfail.2022.08.012 |
0.01 |
|
| 2022 |
Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, et al. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT. Circulation. PMID 36036760 DOI: 10.1161/CIRCULATIONAHA.122.061533 |
0.01 |
|
| 2022 |
Metkus TS, Baird-Zars VM, Alfonso CE, Alviar CL, Barnett CF, Barsness GW, Berg DD, Bertic M, Bohula EA, Burke J, Burstein B, Chaudhry SP, Cooper HA, Daniels LB, Fordyce CB, et al. Critical Care Cardiology Trials Network (CCCTN): a cohort profile. European Heart Journal. Quality of Care & Clinical Outcomes. PMID 36029517 DOI: 10.1093/ehjqcco/qcac055 |
0.01 |
|
| 2022 |
Fagundes A, Berg DD, Park JG, Baird-Zars VM, Newby LK, Barsness GW, Miller PE, van Diepen S, Katz JN, Phreaner N, Roswell RO, Menon V, Daniels LB, Morrow DA, Bohula EA. Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry. Circulation. Cardiovascular Quality and Outcomes. 101161CIRCOUTCOMES12. PMID 35862019 DOI: 10.1161/CIRCOUTCOMES.121.008652 |
0.01 |
|
| 2022 |
Freedman BL, Berg DD, Scirica BM, Bohula EA, Goodrich EL, Sabatine MS, Morrow DA, Bonaca MP. Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trial. Clinical Cardiology. PMID 35855557 DOI: 10.1002/clc.23843 |
0.01 |
|
| 2022 |
Sinha SS, Bohula EA, van Diepen S, Leonardi S, Mebazaa A, Proudfoot AG, Sionis A, Chia YW, Zampieri FG, Lopes RD, Katz JN. The Intersection between Heart Failure and Critical Care Cardiology: An International Perspective on Structure, Staffing, and Design Considerations. Journal of Cardiac Failure. PMID 35843489 DOI: 10.1016/j.cardfail.2022.06.007 |
0.01 |
|
| 2022 |
Bhatt AS, Varshney AS, Goodrich EL, Gong J, Ginder C, Senman BC, Johnson M, Butler K, Woolley AE, de Lemos JA, Morrow DA, Bohula EA. Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. Journal of the American Heart Association. e024451. PMID 35470683 DOI: 10.1161/JAHA.121.024451 |
0.01 |
|
| 2022 |
Patel SM, Jentzer JC, Alviar CL, Baird-Zars VM, Barsness GW, Berg DD, Bohula EA, Daniels LB, DeFilippis AP, Keeley EC, Kontos MC, Lawler PR, Miller PE, Park JG, Roswell RO, et al. A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) Registry. European Heart Journal. Acute Cardiovascular Care. PMID 35134860 DOI: 10.1093/ehjacc/zuac012 |
0.01 |
|
| 2022 |
Berg DD, Alviar CL, Bhatt AS, Baird-Zars VM, Barnett CF, Daniels LB, DeFilippis AP, Fagundes A, Katrapati P, Kenigsberg BB, Guo J, Keller N, Lopes MS, Mody A, Papolos AI, ... ... Bohula EA, et al. Epidemiology of Acute Heart Failure in Critically Ill Patients with COVID-19: An Analysis from the Critical Care Cardiology Trials Network. Journal of Cardiac Failure. PMID 35051622 DOI: 10.1016/j.cardfail.2021.12.020 |
0.01 |
|
| 2022 |
Fagundes A, Berg DD, Bohula EA, Baird-Zars VM, Barnett CF, Carnicelli AP, Chaudhry SP, Guo J, Keeley EC, Kenigsberg BB, Menon V, Miller PE, Newby LK, van Diepen S, Morrow DA, et al. End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry. European Heart Journal. Acute Cardiovascular Care. PMID 34986236 DOI: 10.1093/ehjacc/zuab121 |
0.01 |
|
| 2022 |
Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Bahit MC, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, et al. Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex. Circulation. PMID 34985309 DOI: 10.1161/CIRCULATIONAHA.121.056355 |
0.01 |
|
| 2021 |
Carnicelli AP, Blumer V, Genovese L, Gage A, Agarwal R, Lakdawala NK, Bohula E, Katz JN. The Road Not Yet Traveled: Distinction in Critical Care Cardiology through the Advanced Heart Failure and Transplant Cardiology Training Pathway. Journal of Cardiac Failure. 28: 339-342. PMID 35148880 DOI: 10.1016/j.cardfail.2021.07.014 |
0.01 |
|
| 2021 |
Varshney AS, Omar WA, Goodrich EL, Bhatt AS, Wolley AE, Gong J, Senman BC, Silva D, Levangie MW, Berg DD, Yeh RW, de Lemos JA, Morrow DA, Kazi DS, Bohula EA. Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19 : A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. Heart Failure. CIRCHEARTFAILURE1210. PMID 34789004 DOI: 10.1161/CIRCHEARTFAILURE.121.008477 |
0.01 |
|
| 2021 |
Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry SP, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, et al. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. Journal of Cardiac Failure. 27: 1073-1081. PMID 34625127 DOI: 10.1016/j.cardfail.2021.08.014 |
0.01 |
|
| 2021 |
Sinha SS, Bohula EA, Katz JN. The Nexus of Heart Failure and Critical Care Cardiology. Journal of Cardiac Failure. 27: 1041. PMID 34625125 DOI: 10.1016/j.cardfail.2021.09.004 |
0.01 |
|
| 2021 |
Papolos AI, Kenigsberg BB, Berg DD, Alviar CL, Bohula E, Burke JA, Carnicelli AP, Chaudhry SP, Drakos S, Gerber DA, Guo J, Horowitz JM, Katz JN, Keeley EC, Metkus TS, et al. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams. Journal of the American College of Cardiology. 78: 1309-1317. PMID 34556316 DOI: 10.1016/j.jacc.2021.07.044 |
0.01 |
|
| 2021 |
Berg DD, Bohula EA, Morrow DA. Epidemiology and causes of cardiogenic shock. Current Opinion in Critical Care. PMID 34010224 DOI: 10.1097/MCC.0000000000000845 |
0.01 |
|
| 2021 |
Lawler PR, Berg DD, Park JG, Katz JN, Baird-Zars VM, Barsness GW, Bohula EA, Carnicelli AP, Chaudhry SP, Jentzer JC, Menon V, Metkus T, Nativi-Nicolau J, Phreaner N, Sinha SS, et al. The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry. Critical Care Medicine. PMID 33861557 DOI: 10.1097/CCM.0000000000004948 |
0.01 |
|
| 2021 |
Lau ES, Braunwald E, Morrow DA, Giugliano RP, Antman EM, Gibson CM, Scirica BM, Bohula EA, Wiviott SD, Bhatt DL, Bonaca MP, Cannon CP, Im K, Guo J, Sabatine MS, et al. Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials. Circulation. 143: 685-695. PMID 33587654 DOI: 10.1161/CIRCULATIONAHA.120.052339 |
0.01 |
|
| 2020 |
Metkus TS, Miller PE, Alviar CL, Baird-Zars VM, Bohula EA, Cremer PC, Gerber DA, Jentzer JC, Keeley EC, Kontos MC, Menon V, Park JG, Roswell RO, Schulman SP, Solomon MA, et al. Advanced Respiratory Support in the Contemporary Cardiac ICU. Critical Care Explorations. 2: e0182. PMID 33235999 DOI: 10.1097/CCE.0000000000000182 |
0.01 |
|
| 2020 |
Fordyce CB, Katz JN, Alviar CL, Arslanian-Engoren C, Bohula EA, Geller BJ, Hollenberg SM, Jentzer JC, Sims DB, Washam JB, van Diepen S. Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association. Circulation. CIR0000000000000909. PMID 33115261 DOI: 10.1161/CIR.0000000000000909 |
0.01 |
|
| 2020 |
McCarthy CP, Murphy S, Jones-O'Connor M, Olshan DS, Khambhati JR, Rehman S, Cadigan JB, Cui J, Meyerowitz EA, Philippides G, Friedman LS, Kadar AY, Hibbert K, Natarajan P, Massaro AF, ... Bohula EA, et al. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. Eclinicalmedicine. 100504. PMID 32838244 DOI: 10.1016/j.eclinm.2020.100504 |
0.01 |
|
| 2020 |
Rudski L, Januzzi JL, Rigolin VH, Bohula EA, Blankstein R, Patel AR, Bucciarelli-Ducci C, Vorovich E, Mukherjee M, Rao SV, Beanlands R, Villines TC, Di Carli MF. Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19. Journal of the American College of Cardiology. PMID 32710927 DOI: 10.1016/j.jacc.2020.06.080 |
0.01 |
|
| 2020 |
Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA. A current review of COVID-19 for the cardiovascular specialist. American Heart Journal. 226: 29-44. PMID 32497913 DOI: 10.1016/j.ahj.2020.04.025 |
0.01 |
|
| 2020 |
Piechura LM, Coppolino A, Mody GN, Rinewalt DE, Keshk M, Ogawa M, Seethala R, Bohula EA, Morrow DA, Singh SK, Mallidi HR, Keller SP. Left ventricle unloading strategies in ECMO: A single-center experience. Journal of Cardiac Surgery. PMID 32485030 DOI: 10.1111/jocs.14644 |
0.01 |
|
| 2020 |
Giugliano RP, Pedersen TR, Saver JL, Sever PS, Keech AC, Bohula EA, Murphy SA, Wasserman SM, Honarpour N, Wang H, Lira Pineda A, Sabatine MS. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis. Stroke. STROKEAHA119027759. PMID 32312223 DOI: 10.1161/STROKEAHA.119.027759 |
0.01 |
|
| 2020 |
Katz JN, Sinha SS, Alviar CL, Dudzinski DM, Gage A, Brusca SB, Flanagan MC, Welch T, Geller BJ, Miller PE, Leonardi S, Bohula EA, Price S, Chaudhry SP, Metkus TS, et al. Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective. Journal of the American College of Cardiology. PMID 32305402 DOI: 10.1016/j.jacc.2020.04.029 |
0.01 |
|
| 2020 |
Varshney AS, Berg DD, Katz JN, Baird-Zars VM, Bohula EA, Carnicelli AP, Chaudhry SP, Guo J, Lawler PR, Nativi-Nicolau J, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA. Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. Jama Cardiology. PMID 32293644 DOI: 10.1001/jamacardio.2020.0692 |
0.01 |
|
| 2020 |
Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. Jacc. Basic to Translational Science. PMID 32292848 DOI: 10.1016/j.jacbts.2020.04.002 |
0.01 |
|
| 2020 |
van Diepen S, Tymchak W, Bohula EA, Park JG, Daniels LB, Phreaner N, Barnett CF, Kenigsberg BB, DeFilippis A, Singam NS, Barsness GW, Jentzer JC, Ternus B, Morrow DA, Katz JN, et al. Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry. American Heart Journal. 222: 8-14. PMID 32006910 DOI: 10.1016/J.Ahj.2020.01.005 |
0.01 |
|
| 2019 |
Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S. Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician. Circulation. 140: 2019-2037. PMID 31815538 DOI: 10.1161/CIRCULATIONAHA.119.034512 |
0.01 |
|
| 2019 |
Berg DD, Barnett CF, Kenigsberg BB, Papolos A, Alviar CL, Baird-Zars VM, Barsness GW, Bohula EA, Brennan J, Burke JA, Carnicelli AP, Chaudhry SP, Cremer PC, Daniels LB, DeFilippis AP, et al. Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. Circulation. Heart Failure. 12: e006635. PMID 31707801 DOI: 10.1161/Circheartfailure.119.006635 |
0.01 |
|
| 2019 |
Doehner W, Mazighi M, Hofmann BM, Lautsch D, Hindricks G, Bohula EA, Byrne RA, Camm AJ, Casadei B, Caso V, Cognard C, Diener HC, Endres M, Goldstein P, Halliday A, et al. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table. European Journal of Preventive Cardiology. 2047487319873460. PMID 31569966 DOI: 10.1177/2047487319873460 |
0.01 |
|
| 2019 |
Qamar A, Giugliano RP, Bohula EA, Park JG, Jarolim P, Murphy SA, Blazing MA, Califf RM, Cannon CP, Braunwald E, Morrow DA. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial. Journal of the American College of Cardiology. 74: 1057-1068. PMID 31439215 DOI: 10.1016/J.Jacc.2019.06.038 |
0.01 |
|
| 2019 |
Bohula EA, Katz JN, van Diepen S, Alviar CL, Baird-Zars VM, Park JG, Barnett CF, Bhattal G, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis A, Granger CB, et al. Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. Jama Cardiology. PMID 31339509 DOI: 10.1001/Jamacardio.2019.2467 |
0.01 |
|
| 2019 |
Bach RG, Cannon CP, Giugliano RP, White JA, Lokhnygina Y, Bohula EA, Califf RM, Braunwald E, Blazing MA. Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. PMID 31314050 DOI: 10.1001/Jamacardio.2019.2306 |
0.01 |
|
| 2019 |
Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, et al. Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. Circulation. Cardiovascular Quality and Outcomes. 12: e005618. PMID 30879324 DOI: 10.1161/Circoutcomes.119.005618 |
0.01 |
|
| 2019 |
Zelniker TA, Jarolim P, Silverman MG, Bohula EA, Park JG, Bonaca MP, Scirica BM, Morrow DA. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS. Clinical Chemistry and Laboratory Medicine. PMID 30710475 DOI: 10.1515/cclm-2018-1081 |
0.01 |
|
| 2019 |
Bohula EA, Wiviott SD, Scirica BM. Lorcaserin Safety in Overweight or Obese Patients. The New England Journal of Medicine. 380: 100. PMID 30601747 DOI: 10.1056/NEJMc1813971 |
0.01 |
|
| 2018 |
Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, et al. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. Circulation. PMID 30586726 DOI: 10.1161/Circulationaha.118.038341 |
0.01 |
|
| 2018 |
Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, et al. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet (London, England). PMID 30293771 DOI: 10.1016/S0140-6736(18)32328-6 |
0.01 |
|
| 2018 |
Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, et al. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. The New England Journal of Medicine. PMID 30145941 DOI: 10.1056/Nejmoa1808721 |
0.01 |
|
| 2018 |
Watson RA, Bohula EA, Gilliland TC, Sanchez PA, Berg DD, Morrow DA. Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit. European Heart Journal. Acute Cardiovascular Care. 2048872618789053. PMID 30033736 DOI: 10.1177/2048872618789053 |
0.01 |
|
| 2018 |
Bohula EA, Wiviott SD, Giugliano RP, Park JG, Murphy SA, Cannon CP, Braunwald E. Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". Circulation. 137: 2662-2663. PMID 29891625 DOI: 10.1161/CIRCULATIONAHA.118.034500 |
0.01 |
|
| 2018 |
Bohula EA, Scirica BM, Fanola C, Inzucchi SE, Keech A, McGuire DK, Smith SR, Abrahamsen T, Francis BH, Miao W, Perdomo CA, Satlin A, Wiviott SD, Sabatine MS. Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial. American Heart Journal. 202: 39-48. PMID 29803985 DOI: 10.1016/J.Ahj.2018.03.012 |
0.01 |
|
| 2018 |
Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK. How does the TRS 2°P score relate to real-world patients? European Heart Journal. Cardiovascular Pharmacotherapy. 4: 72-74. PMID 29554293 DOI: 10.1093/ehjcvp/pvy004 |
0.01 |
|
| 2018 |
Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, Pineda AL, Honarpour N, Wang H, Murphy SA, Keech A, Pedersen TR, Sabatine MS. Inflammatory and Cholesterol Risk in the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk). Circulation. PMID 29530884 DOI: 10.1161/CIRCULATIONAHA.118.034032 |
0.01 |
|
| 2017 |
Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalan R, Spinar J, Park JG, White JA, Bohula E, Braunwald E. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT. Circulation. PMID 29263150 DOI: 10.1161/Circulationaha.117.030950 |
0.01 |
|
| 2017 |
Bergmark BA, Bhatt DL, Braunwald E, Morrow DA, Steg PG, Gurmu Y, Cahn A, Mosenzon O, Raz I, Bohula E, Scirica BM. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. PMID 29196298 DOI: 10.2337/Dc17-1736 |
0.01 |
|
| 2017 |
Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Journal of the American Heart Association. 6. PMID 29151034 DOI: 10.1161/Jaha.117.006901 |
0.01 |
|
| 2017 |
Bohula EA, Wiviott SD, Giugliano RP, Blazing MA, Park JG, Murphy SA, White JA, Mach F, Van de Werf FJ, Dalby AJ, White HD, Tershakovec AM, Cannon CP, Braunwald E. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT. Circulation. PMID 28972004 DOI: 10.1161/Circulationaha.117.029095 |
0.01 |
|
| 2017 |
Bohula EA, Morrow DA, Giugliano RP, Cannon CP, Braunwald E. Reply: Ezetimibe, Risk Stratification, and Secondary Prevention. Journal of the American College of Cardiology. 70: 1200. PMID 28838375 DOI: 10.1016/J.Jacc.2017.05.074 |
0.01 |
|
| 2017 |
Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, Murphy SA, White JA, Kesaniemi YA, Pedersen TR, Brady AJ, Mitchel Y, Cannon CP, Braunwald E. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. Journal of the American College of Cardiology. 69: 911-921. PMID 28231942 DOI: 10.1016/J.Jacc.2016.11.070 |
0.01 |
|
| 2017 |
Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry. 63: 307-315. PMID 28062625 DOI: 10.1373/Clinchem.2016.264788 |
0.01 |
|
| 2016 |
Bohula EA, Antman EM. Management of Non-ST-Elevation Myocardial Infarction: The Bright Gleam of Progress, but Much Work Remains. Jama. 316: 1045-7. PMID 27574716 DOI: 10.1001/jama.2016.11940 |
0.01 |
|
| 2016 |
Eisen A, Cannon CP, Blazing MA, Bohula EA, Park JG, Murphy SA, White JA, Giugliano RP, Braunwald E. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. European Heart Journal. PMID 27569841 DOI: 10.1093/Eurheartj/Ehw377 |
0.01 |
|
| 2016 |
Bohula EA, Bonaca MP, Braunwald E, Aylward PE, Corbalan R, De Ferrari GM, He P, Lewis BS, Merlini PA, Murphy SA, Sabatine MS, Scirica BM, Morrow DA. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Prior Myocardial Infarction. Circulation. PMID 27440003 DOI: 10.1161/Circulationaha.115.019861 |
0.01 |
|
| 2016 |
Bohula EA, Giugliano RP, Ruff CT, Kuder JF, Murphy SA, Antman EM, Braunwald E. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation. 134: 24-36. PMID 27358434 DOI: 10.1161/Circulationaha.116.022361 |
0.01 |
|
| 2016 |
Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White J, Tershakovec AM, Blazing MA, Braunwald E. Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT". Circulation. 133: e463. PMID 27022050 DOI: 10.1161/Circulationaha.116.020947 |
0.01 |
|
| 2016 |
Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, Reist C, Im K, Bohula EA, Isaza D, Lopez-Sendon J, Dellborg M, Kher U, Tershakovec AM, Braunwald E. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. Journal of the American College of Cardiology. 67: 353-61. PMID 26821621 DOI: 10.1016/J.Jacc.2015.10.077 |
0.01 |
|
| 2015 |
Bohula EA, Aylward PE, Bonaca MP, Corbalan RL, Kiss RG, Murphy SA, Scirica BM, White H, Braunwald E, Morrow DA. The Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients with Prior Myocardial Infarction and no History of Stroke or TIA: Results from TRA 2°P-TIMI 50. Circulation. PMID 26338971 DOI: 10.1161/Circulationaha.114.015042 |
0.01 |
|
| 2015 |
Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, Tershakovec AM, Blazing MA, Braunwald E. Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT. Circulation. 132: 1224-33. PMID 26330412 DOI: 10.1161/Circulationaha.115.018381 |
0.01 |
|
| 2015 |
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. The New England Journal of Medicine. 372: 2387-97. PMID 26039521 DOI: 10.1056/NEJMoa1410489 |
0.01 |
|
| 2015 |
Berg DD, Sukul D, O'Brien M, Scirica BM, Sobieszczyk PS, Olenchock BA, Bohula EA, Morrow DA. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. European Heart Journal. Acute Cardiovascular Care. PMID 25931573 DOI: 10.1177/2048872615584079 |
0.01 |
|
| 2003 |
Bohula EA, Playford MP, Macaulay VM. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment. Anti-Cancer Drugs. 14: 669-82. PMID 14551500 DOI: 10.1097/00001813-200310000-00001 |
0.01 |
|
| 2003 |
Barelle CJ, Bohula EA, Kron SJ, Wessels D, Soll DR, Schäfer A, Brown AJ, Gow NA. Asynchronous cell cycle and asymmetric vacuolar inheritance in true hyphae of Candida albicans. Eukaryotic Cell. 2: 398-410. PMID 12796285 DOI: 10.1128/Ec.2.3.398-410.2003 |
0.01 |
|
| 2003 |
Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM, Macaulay VM. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. The Journal of Biological Chemistry. 278: 15991-7. PMID 12604614 DOI: 10.1074/Jbc.M300714200 |
0.01 |
|
| Hide low-probability matches. |